Panakes Partners

Panakes Partners SGR S.p.A. is a prominent Italian specialist healthcare venture capital firm based in Milan, Italy, investing in European and Israeli companies operating in the healthcare sector including medical devices, diagnostic devices, biotechnology, digital health, and adjacent healthcare-technology themes. The firm was founded in 2016 by Managing Partners Alessio Beverina (previously at Mandarin Capital Partners and Siparex), Diana Saraceni (previously at 360 Capital Partners), and Fabrizio Landi (prominent Italian biotech executive and life-sciences industry-veteran). Panakes operates as one of Italy's few dedicated healthcare / life-sciences-specialist VC firms and invests primarily at Series A and Series B stages with typical initial check sizes in the EUR 2 to 10 million range, regulated by the Bank of Italy (Banca d'Italia) and Italian securities regulator Consob. The firm has raised multiple institutional funds (Panakes Fund I at approximately EUR 80 million in 2016, Panakes Fund II at approximately EUR 150 million in 2021, with follow-on extensions) with aggregate AUM exceeding EUR 230 million+ across vintages. Notable portfolio companies include D-Orbit (Italian space-logistics SPAC), Skyler (medical devices), Piramal Glass, and various European and Israeli medical-device and biotech start-ups.